AMAG Pharmaceuticals Top Insiders

AMAG Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (3.06) % which means that it has lost $3.06 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (62.88) %, meaning that it created substantial loss on money invested by shareholders. AMAG Pharmaceuticals' management efficiency ratios could be used to measure how well AMAG Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.

AMAG Pharmaceuticals Workforce Comparison

The company has Profit Margin (PM) of (77.18) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (13.88) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $13.88.

AMAG Pharmaceuticals Notable Stakeholders

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the AMAG Pharmaceuticals information on this page should be used as a complementary analysis to other AMAG Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

If you are still planning to invest in AMAG Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AMAG Pharmaceuticals' history and understand the potential risks before investing.